{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:52:01Z","timestamp":1792003921856,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00392-023-02359-1","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T10:02:26Z","timestamp":1702980146000},"page":"1485-1500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"113","author":[{"given":"Eduardo","family":"Flores-Umanzor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Cepas-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Keshvara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyre","family":"Alvarez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Osten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Freixa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Horlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Abrahamyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"2359_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 12:7\u201311","journal-title":"Kidney Int Suppl"},{"key":"2359_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","volume":"16","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G (2021) Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke 16:217\u2013221","journal-title":"Int J Stroke"},{"key":"2359_CR3","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","volume":"39","author":"MP Turakhia","year":"2018","unstructured":"Turakhia MP, Blankestijn PJ, Carrero JJ et al (2018) Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J 39:2314\u20132325","journal-title":"Eur Heart J"},{"key":"2359_CR4","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","volume":"123","author":"A Alonso","year":"2011","unstructured":"Alonso A, Lopez FL, Matsushita K et al (2011) Chronic kidney disease is associated with the incidence of atrial fibrillation. Circulation 123:2946\u20132953","journal-title":"Circulation"},{"key":"2359_CR5","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1161\/STROKEAHA.113.001701","volume":"44","author":"H Reinecke","year":"2013","unstructured":"Reinecke H, Engelbertz C, Sch\u00e4bitz WR (2013) Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants. Stroke 44:2935\u20132941","journal-title":"Stroke"},{"key":"2359_CR6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2215\/CJN.04060318","volume":"13","author":"JJ Carrero","year":"2018","unstructured":"Carrero JJ, Trevisan M, Sood MM et al (2018) Incident atrial fibrillation and the risk of stroke in adults with chronic kidney disease: The Stockholm CREAtinine Measurements (SCREAM) Project. Clin J Am Soc Nephrol 13:1314\u20131320","journal-title":"Clin J Am Soc Nephrol"},{"key":"2359_CR7","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1161\/STROKEAHA.119.025442","volume":"50","author":"DM Kelly","year":"2019","unstructured":"Kelly DM, Rothwell PM (2019) Does chronic kidney disease predict stroke risk independent of blood pressure? Stroke 50:3085\u20133092","journal-title":"Stroke"},{"key":"2359_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373\u2013498","journal-title":"Eur Heart J"},{"key":"2359_CR9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/clc.23196","volume":"42","author":"V Aursulesei","year":"2019","unstructured":"Aursulesei V, Costache II (2019) Anticoagulation in chronic kidney disease: from guidelines to clinical practice. Clin Cardiol 42:774\u2013782","journal-title":"Clin Cardiol"},{"key":"2359_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1105594","volume":"367","author":"JB Olesen","year":"2012","unstructured":"Olesen JB, Lip GY, Kamper AL et al (2012) Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 367:625\u2013635","journal-title":"N Engl J Med"},{"key":"2359_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"2359_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/XEB.0000000000000064","volume":"13","author":"S Moola","year":"2015","unstructured":"Moola S, Munn Z, Sears K et al (2015) Conducting systematic reviews of association (etiology): The Joanna Briggs Institute\u2019s approach. Int J Evid Based Healthc 13:163\u2013169","journal-title":"Int J Evid Based Healthc"},{"key":"2359_CR13","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S et al (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18:2127\u20132133","journal-title":"JBI Evid Synth"},{"key":"2359_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"2359_CR15","first-page":"40","volume":"7","author":"G Schwarzer","year":"2007","unstructured":"Schwarzer G (2007) meta: an R package for meta-analysis. R News 7:40\u201345","journal-title":"R News"},{"key":"2359_CR16","doi-asserted-by":"crossref","unstructured":"Benito-Gonz\u00e1lez T, Quir\u00f3s A, Torres-Saura F, Cruz-Gonz\u00e1lez I, Ruiz-Nodar JM, P\u00e9rez de Prado A (2022) Design and interim results of a registry of left atrial appendage occlusion with the Watchman device in patients on hemodialysis: EPIC06-WATCH-HD. Rev Esp Cardiol (Engl Ed) 75:179\u2013180","DOI":"10.1016\/j.rec.2021.07.014"},{"key":"2359_CR17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.rec.2018.12.007","volume":"72","author":"I Cruz-Gonz\u00e1lez","year":"2019","unstructured":"Cruz-Gonz\u00e1lez I, Trejo-Velasco B, Fraile MP, Barreiro-P\u00e9rez M, Gonz\u00e1lez-Ferreiro R, S\u00e1nchez PL (2019) Left atrial appendage occlusion in hemodialysis patients: initial experience. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 72:792\u2013793","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"2359_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/aor.13603","volume":"44","author":"M Xipell","year":"2020","unstructured":"Xipell M, Flores-Umanzor E, Ojeda R et al (2020) Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: a single center experience. Artif Organs 44:513\u2013521","journal-title":"Artif Organs"},{"key":"2359_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40620-020-00774-5","volume":"34","author":"S Genovesi","year":"2021","unstructured":"Genovesi S, Porcu L, Slaviero G et al (2021) Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis. J Nephrol 34:63\u201373","journal-title":"J Nephrol"},{"key":"2359_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijcard.2016.01.003","volume":"207","author":"J Kefer","year":"2016","unstructured":"Kefer J, Tzikas A, Freixa X et al (2016) Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Int J Cardiol 207:335\u2013340","journal-title":"Int J Cardiol"},{"key":"2359_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/00015385.2019.1585643","volume":"75","author":"M Brockmeyer","year":"2020","unstructured":"Brockmeyer M, Wolff G, Krieger T et al (2020) Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk. Acta Cardiol 75:312\u2013320","journal-title":"Acta Cardiol"},{"key":"2359_CR22","doi-asserted-by":"crossref","unstructured":"Benini Tapias J, Flores-Umanzor E, Cepas-Guill\u00e9n PL et al (2021) Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: a single center experience. Nefrologia (Engl Ed)","DOI":"10.1016\/j.nefroe.2022.05.006"},{"key":"2359_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00392-020-01638-5","volume":"110","author":"C Fastner","year":"2021","unstructured":"Fastner C, Brachmann J, Lewalter T et al (2021) Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry. Clin Res Cardiol 110:12\u201320","journal-title":"Clin Res Cardiol"},{"key":"2359_CR24","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1007\/s00380-018-1157-x","volume":"33","author":"X Xue","year":"2018","unstructured":"Xue X, Jiang L, Duenninger E et al (2018) Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center. Heart Vessels 33:1068\u20131075","journal-title":"Heart Vessels"},{"key":"2359_CR25","first-page":"43","volume":"18","author":"W Michlicka-K\u0142y\u015b","year":"2022","unstructured":"Michlicka-K\u0142y\u015b W, Kalarus Z, Podolecki T, Mitr\u0119ga K, Streb W (2022) Long-term results of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and chronic kidney disease. Postepy Kardiol Interwencyjnej 18:43\u201349","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"2359_CR26","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jcin.2021.06.008","volume":"14","author":"KR Ahuja","year":"2021","unstructured":"Ahuja KR, Ariss RW, Nazir S et al (2021) The association of chronic kidney disease with outcomes following percutaneous left atrial appendage closure. JACC Cardiovasc Interv 14:1830\u20131839","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"2359_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.hroo.2021.08.002","volume":"O2","author":"MB Munir","year":"2021","unstructured":"Munir MB, Khan MZ, Darden D et al (2021) Association of chronic kidney disease and end-stage renal disease with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: Insights from the national inpatient sample of 36,065 procedures. Heart Rhythm O2(2):472\u2013479","journal-title":"Heart Rhythm"},{"key":"2359_CR28","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/pace.14537","volume":"45","author":"S Jamal","year":"2022","unstructured":"Jamal S, Mughal MS, Kichloo A et al (2022) Left atrial appendage closure using WATCHMAN device in chronic kidney disease and end-stage renal disease patients. Pacing Clin Electrophysiol 45:866\u2013873","journal-title":"Pacing Clin Electrophysiol"},{"key":"2359_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/europace\/euz358","volume":"22","author":"TS Potpara","year":"2020","unstructured":"Potpara TS, Ferro C, Lip GYH et al (2020) Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association\/European Dialysis and Transplantation Association (ERA\/EDTA) physician-based survey. Europace 22:496\u2013505","journal-title":"Europace"},{"key":"2359_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H et al (2019) 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 74:104\u2013132","journal-title":"J Am Coll Cardiol"},{"key":"2359_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2215\/CJN.02170218","volume":"14","author":"N Jain","year":"2019","unstructured":"Jain N, Reilly RF (2019) Clinical pharmacology of oral anticoagulants in patients with kidney disease. Clin J Am Soc Nephrol 14:278\u2013287","journal-title":"Clin J Am Soc Nephrol"},{"key":"2359_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ahj.2016.09.016","volume":"184","author":"H Van Der Meersch","year":"2017","unstructured":"Van Der Meersch H, De Bacquer D, De Vriese AS (2017) Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis. Am Heart J 184:37\u201346","journal-title":"Am Heart J"},{"key":"2359_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJV et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"key":"2359_CR34","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093\u20132104","journal-title":"N Engl J Med"},{"key":"2359_CR35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"2359_CR36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"2359_CR37","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","volume":"146","author":"SD Pokorney","year":"2022","unstructured":"Pokorney SD, Chertow GM, Al-Khalidi HR et al (2022) Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial. Circulation 146:1735\u20131745","journal-title":"Circulation"},{"key":"2359_CR38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","volume":"147","author":"H Reinecke","year":"2023","unstructured":"Reinecke H, Engelbertz C, Bauersachs R et al (2023) A randomized controlled trial comparing apixaban with the vitamin K antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study. Circulation 147:296\u2013309","journal-title":"Circulation"},{"key":"2359_CR39","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/jcph.628","volume":"56","author":"X Wang","year":"2016","unstructured":"Wang X, Tirucherai G, Marbury TC et al (2016) Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis. J Clin Pharmacol 56:628\u2013636","journal-title":"J Clin Pharmacol"},{"key":"2359_CR40","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","volume":"138","author":"KC Siontis","year":"2018","unstructured":"Siontis KC, Zhang X, Eckard A et al (2018) Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States. Circulation 138:1519\u20131529","journal-title":"Circulation"},{"key":"2359_CR41","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.kint.2021.08.028","volume":"100","author":"J Eikelboom","year":"2021","unstructured":"Eikelboom J, Floege J, Thadhani R, Weitz JI, Winkelmayer WC (2021) Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney Int 100:1199\u20131207","journal-title":"Kidney Int"},{"key":"2359_CR42","first-page":"850","volume":"19","author":"M Sobolev","year":"2017","unstructured":"Sobolev M, Shiloh AL, Di Biase L, Slovut DP (2017) Ultrasound-guided cannulation of the femoral vein in electrophysiological procedures: a systematic review and meta-analysis. Europace 19:850\u2013855","journal-title":"Europace"},{"key":"2359_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jcin.2023.05.008","volume":"16","author":"JD Clarke","year":"2023","unstructured":"Clarke JD, Higgins AY, Wang Y et al (2023) Impact of preprocedure imaging for left atrial appendage occlusion: insights from the NCDR LAAO registry. JACC Cardiovasc Interv 16:1317\u20131328","journal-title":"JACC Cardiovasc Interv"},{"key":"2359_CR44","doi-asserted-by":"crossref","unstructured":"So CY, Kang G, Villablanca PA et al (2021) Additive value of preprocedural computed tomography planning versus stand\u2010alone transesophageal echocardiogram guidance to left atrial appendage occlusion: comparison of real\u2010world practice. J Am Heart Assoc 10:e020615","DOI":"10.1161\/JAHA.120.020615"},{"key":"2359_CR45","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.nefroe.2022.01.008","volume":"41","author":"C Escobar","year":"2021","unstructured":"Escobar C, Aranda U, Palacios B et al (2021) Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain. Nefrolog\u00eda (English Edition) 41:670\u2013688","journal-title":"Nefrolog\u00eda (English Edition)"},{"key":"2359_CR46","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1681\/ASN.2015050535","volume":"27","author":"AO Molnar","year":"2016","unstructured":"Molnar AO, Bota SE, Garg AX et al (2016) The risk of major hemorrhage with CKD. J Am Soc Nephrol 27:2825\u20132832","journal-title":"J Am Soc Nephrol"},{"key":"2359_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jth.13904","volume":"16","author":"G Ocak","year":"2018","unstructured":"Ocak G, Rookmaaker MB, Algra A et al (2018) Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study. J Thromb Haemost 16:65\u201373","journal-title":"J Thromb Haemost"},{"key":"2359_CR48","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1056\/NEJM196903272801301","volume":"280","author":"G Eknoyan","year":"1969","unstructured":"Eknoyan G, Wacksman SJ, Glueck HI, Will JJ (1969) Platelet function in renal failure. N Engl J Med 280:677\u2013681","journal-title":"N Engl J Med"},{"key":"2359_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ki.1994.274","volume":"46","author":"TJ Rabelink","year":"1994","unstructured":"Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ (1994) Thrombosis and hemostasis in renal disease. Kidney Int 46:287\u2013296","journal-title":"Kidney Int"},{"key":"2359_CR50","doi-asserted-by":"crossref","unstructured":"Mesnier J, Cruz-Gonz\u00e1lez I, Arzamendi D et al (2022) Incidence and predictors of early death in patients undergoing percutaneous left\u00a0atrial appendage closure. JACC Clin Electrophysiol 8:1093\u20131102","DOI":"10.1016\/j.jacep.2022.06.012"},{"key":"2359_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcin.2013.06.016","volume":"7","author":"TT Tsai","year":"2014","unstructured":"Tsai TT, Patel UD, Chang TI et al (2014) Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv 7:1\u20139","journal-title":"JACC Cardiovasc Interv"},{"key":"2359_CR52","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1016\/j.jacc.2020.09.582","volume":"76","author":"G Armijo","year":"2020","unstructured":"Armijo G, Estevez-Loureiro R, Carrasco-Chinchilla F et al (2020) Acute kidney injury after percutaneous edge-to-edge mitral repair. J Am Coll Cardiol 76:2463\u20132473","journal-title":"J Am Coll Cardiol"},{"key":"2359_CR53","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1002\/ccd.29711","volume":"98","author":"S Nazir","year":"2021","unstructured":"Nazir S, Ahuja KR, Ariss RW et al (2021) Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure. Catheter Cardiovasc Interv 98:E839\u2013E846","journal-title":"Catheter Cardiovasc Interv"},{"key":"2359_CR54","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00392-019-01524-9","volume":"109","author":"A Sedaghat","year":"2020","unstructured":"Sedaghat A, Vij V, Streit SR et al (2020) Incidence, predictors, and relevance of acute kidney injury in patients undergoing left atrial appendage closure with Amplatzer occluders: a multicentre observational study. Clin Res Cardiol 109:444\u2013453","journal-title":"Clin Res Cardiol"},{"key":"2359_CR55","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jcin.2018.03.022","volume":"11","author":"L Nombela-Franco","year":"2018","unstructured":"Nombela-Franco L, Rod\u00e9s-Cabau J, Cruz-Gonzalez I et al (2018) Incidence, predictors, and prognostic value of acute kidney injury among patients undergoing left atrial appendage closure. JACC Cardiovasc Interv 11:1074\u20131083","journal-title":"JACC Cardiovasc Interv"},{"key":"2359_CR56","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1161\/STROKEAHA.120.029680","volume":"52","author":"DM Kelly","year":"2021","unstructured":"Kelly DM, Ademi Z, Doehner W et al (2021) Chronic kidney disease and cerebrovascular disease. Stroke 52:e328\u2013e346","journal-title":"Stroke"},{"key":"2359_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","volume":"78","author":"T Simard","year":"2021","unstructured":"Simard T, Jung RG, Lehenbauer K et al (2021) Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol 78:297\u2013313","journal-title":"J Am Coll Cardiol"},{"key":"2359_CR58","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.jcin.2023.05.045","volume":"16","author":"P Cepas-Guill\u00e9n","year":"2023","unstructured":"Cepas-Guill\u00e9n P, Flores-Umanzor E, Leduc N et al (2023) Impact of device implant depth after left atrial appendage occlusion. JACC Cardiovasc Interv 16:2139\u20132149","journal-title":"JACC Cardiovasc Interv"},{"key":"2359_CR59","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","volume":"4","author":"M Alkhouli","year":"2018","unstructured":"Alkhouli M, Busu T, Shah K, Osman M, Alqahtani F, Raybuck B (2018) Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis. JACC Clin Electrophysiol 4:1629\u20131637","journal-title":"JACC Clin Electrophysiol"},{"key":"2359_CR60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00392-018-1401-5","volume":"108","author":"A Sedaghat","year":"2019","unstructured":"Sedaghat A, Al-Kassou B, Vij V et al (2019) Contrast-free, echocardiography-guided left atrial appendage occlusion (LAAo): a propensity-matched comparison with conventional LAAo using the AMPLATZER\u2122 Amulet\u2122 device. Clin Res Cardiol 108:333\u2013340","journal-title":"Clin Res Cardiol"},{"key":"2359_CR61","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.hrthm.2022.01.036","volume":"19","author":"M Magnocavallo","year":"2022","unstructured":"Magnocavallo M, Della Rocca DG, Gianni C et al (2022) Zero contrast left atrial appendage occlusion and peridevice leak closure in patients with advanced kidney disease. Heart Rhythm 19:1013\u20131014","journal-title":"Heart Rhythm"},{"key":"2359_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.amjcard.2023.04.027","volume":"198","author":"DI Blusztein","year":"2023","unstructured":"Blusztein DI, Gogia S, Hahn RT et al (2023) Zero-contrast left atrial appendage occlusion using a hybrid echocardiography-fluoroscopy technique without iodinated contrast. Am J Cardiol 198:53\u201355","journal-title":"Am J Cardiol"},{"key":"2359_CR63","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jcin.2022.10.024","volume":"16","author":"JE Nielsen-Kudsk","year":"2023","unstructured":"Nielsen-Kudsk JE, Berti S, Caprioglio F et al (2023) Intracardiac echocardiography to guide watchman FLX implantation: the ICE LAA study. JACC Cardiovasc Interv 16:643\u2013651","journal-title":"JACC Cardiovasc Interv"},{"key":"2359_CR64","unstructured":"Saw J, Holmes DR, Cavalcante JL et al SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure. JACC: cardiovascular interventions; 0"},{"key":"2359_CR65","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ccd.30559","volume":"101","author":"T Fink","year":"2023","unstructured":"Fink T, Paitazoglou C, Bergmann MW et al (2023) Left atrial appendage closure in end-stage renal disease and hemodialysis: Data from a German multicenter registry. Catheter Cardiovasc Interv 101:610\u2013619","journal-title":"Catheter Cardiovasc Interv"},{"key":"2359_CR66","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"2359_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amjcard.2020.12.081","volume":"145","author":"L Faroux","year":"2021","unstructured":"Faroux L, Cruz-Gonz\u00e1lez I, Arzamendi D et al (2021) Effect of glomerular filtration rates on outcomes following percutaneous left atrial appendage closure. Am J Cardiol 145:77\u201384","journal-title":"Am J Cardiol"},{"key":"2359_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12872-019-1097-0","volume":"19","author":"B Luani","year":"2019","unstructured":"Luani B, Genz C, Herold J et al (2019) Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN\u2122 device. BMC Cardiovasc Disord 19:112","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02359-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02359-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02359-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T14:03:26Z","timestamp":1727100206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02359-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2359"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02359-1","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"14 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}